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Abstract.  Transferrin (Tf) receptor-variant Chinese 
hamster ovary cells have been isolated by selection for 
resistance to two Tf-toxin conjugates. The hybrid 
toxins contain Tf covalently linked to ricin A  chain or 
a  genetically engineered diphtheria toxin fragment. 
The Tf-receptor-variant (TRV) cells do not have de- 
tectable cell-surface Tf receptor; they do not bind 
fluorescein-Tf or ~25I-Tf. TRV cells are at least 100-fold 
more resistant to the Tf-diphtheria toxin conjugate than 
are the parent cells. The TRV cells have retained sen- 
sitivity to native diphtheria toxin, indicating that the 
increased resistance to the conjugate is correlated with 
the loss of Tf binding. The endocytosis of fluorescein- 
labeled t1:-macroglobulin is normal in TRV cells, 
demonstrating that the defect does not pleiotropically 
affect endocytosis. 
Since these cells lack endogenous Tf receptor activ- 
ity, they are ideally suited for studies of the functional 
expression of normal or altered Tf receptors intro- 
duced into the cells by cDNA transfection. One advan- 
tage of this system is that Tf binding and uptake can 
be used to monitor the behavior of the transfected 
receptor. 
A  cDNA clone of the human Tf receptor has been 
transfected into TRV cells. In the stably expressing 
transfectants, the behavior of the human receptor is 
very similar to that of the endogenous Chinese ham- 
ster ovary cell "If receptor.  Tf binds to cell surface 
receptors,  and is internalized into the para-Golgi re- 
gion of the cell. Iron is released from Tf, and the 
apo-Tf and its receptor are recycled back to the cell 
surface. Thus, the TRV cells can be used to study the 
behavior of genetically altered Tf receptors in the ab- 
sence of interfering effects from endogenous receptors. 
T 
RANSVERRIN (Tf) ~ is an iron-carrying serum glyco- 
protein  responsible  for  Fe  +3  delivery  to  vertebrate 
cells (1). Diferric Tf uptake is mediated by binding to 
a  specific cell surface receptor (20).  Once bound, the Tf- 
receptor complex is internalized, via receptor-mediated en- 
docytosis, into an acidic intracellular compartment (for re- 
view see reference 8) where the acidic pH facilitates Fe  ÷3 
release from transferrin. The qY receptor (Tf-R) and apo-Tf 
are recycled back to the cell surface. At physiological ex- 
tracellular pH apo-Tf is released from the receptor, and the 
recycled receptor participates in multiple rounds of internal- 
ization (4, 6). 
The general process of receptor-mediated endocytosis has 
been morphologically well characterized for a  number of 
ligands in a variety of cell types (for review see reference 7). 
Little is known about the features of the receptors that serve 
to signal internalization and intracellular routing. The avail- 
1. Abbreviations used in this paper: DT, diphtheria toxin; f-TE fluorescein 
transferrin; med 2,  medium consisting of 150 mM NaC1,  20 mM Hepes 
pH 7.4,  1 mM CaCl2,  5  mM KCI,  1 mM MgCl2;  Tf, transferrin; Tf-R, 
transferfin receptor;  Tf-RA,  transferrin-ricin A  chain;  TRV,  transferrin 
receptor variant. 
ability of cDNA clone of the human Tf-R (17, 26) provides 
a direct approach to these questions since the cloned gene 
can be specifically mutated in vitro and transfected into cells. 
The effect of specific mutations on receptor function can then 
be characterized. An ideal cell line for such studies would 
be one that is deficient in Tf-R expression. Tf-R is expressed 
on most cultured cell lines, presumably reflecting the nutri- 
tional requirement for iron (10). Thus, studies of the trans- 
fected receptor would necessarily be performed in a back- 
ground of  endogenous Tf-R. The presence of  the endogenous 
receptor would prohibit the use of "If binding and uptake in 
the characterization of the transfected receptor, although the 
expression of the receptor could be monitored using anti-hu- 
man Tf-R monoclonal antibodies.  Mouse L  cell transfor- 
mants expressing the human Tf-R have been isolated using 
human specific monoclonal antibodies (15, 19). 
Tf uptake in Chinese hamster ovary (CHO) cells has been 
characterized, and the properties are similar to those found 
in other cell types studied (30).  Mutant CHO cells that can- 
not release iron from "IT are able to transport sufficient iron 
to support cell growth, apparently by increased uptake of 
iron salts (14). Since CHO cells have an alternative to qT-me- 
diated iron uptake, it should be possible to select for ceils that 
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used for studies of the functioning of the transfected human 
Tf-R. A further advantage of using CHO cells for these stud- 
ies is that they have been used for many studies of receptor- 
mediated endocytosis, including the isolation of mutant cells 
defective in receptor-mediated endocytosis (12, 24). 
A strategy for isolating Tf-R-variant CHO cells is to select 
for resistance to a Tf-toxin conjugate. In the conjugate, Tf 
replaces the cell surface-binding domain of the toxin. The 
specificity of the cytotoxicity  of the conjugate is conferred by 
Tf  binding to cells. The rationale behind this approach is that 
"If-R-variant cells would not specifically bind the conjugate 
and would thereby display greater resistance than cells ex- 
pressing high affinity Tf-R. The efficacy of isolating cells 
deficient in the expression of cell surface markers by selec- 
tion with toxin conjugates has been previously established 
(18, 23). Such an approach, using a Tf-ricin A chain (Tf-RA) 
conjugate, has been used to isolate a Tf-R-modified human 
leukemia cell line (22). 
In this study we report the isolation of Tf-R-variant CHO 
cells by selection for resistance to two Tf conjugate toxins: 
a  ricin A  chain- and a  modified diphtheria toxin (DT)-Tf 
conjugate.  The  Tf-R-variant cells  do not bind detectable 
amounts of Tf. A human Tf-R cDNA has been transfected 
into these cells. The behavior of the human receptor in these 
cells is very similar to that of the endogenous receptor in 
wild type CHO cells. 59Fe is efficiently internalized by the 
transfectants when  presented  to  the  cells  as  diferric  Tf, 
demonstrating that the human receptor is biologically active. 
These results demonstrate the utility of using the receptor- 
variant CHO cells for structure-function studies of the hu- 
man Tf-R. 
Materials and Methods 
Cells and Cell Culture 
WTB Chinese hamster ovary cells were used as the parental cell line (29). 
Ceils were maintained in Ham's nutrient F12 medium (Gibco, Grand Island, 
NY) supplemented with 5 % FCS (referred to as complete medium), or in 
Ham's F12 containing 500 ng/ml Se203, 5 llg/m] insulin, and 1 mg/ml BSA 
fraction V (referred to as serum-free medium) at 3"/°C in a humidified at- 
mosphere of 5 % CO2 in air.  Single cell colony lines were isolated by two 
rounds of cloning ring colony purification. 
Ligands 
Human Tf (Sigma Chemical Co., St. Louis, MO) was further purified by 
Sephacryl S-300 gel filtration. Diferric Tf, fluorescein Tf (f-T0, and I:ZI-Tf 
were prepared as described previously (30). 59FeCl3 was purchased from 
New England Nuclear (Cambridge,  MA).  Tf59Fe2 was prepared by the 
nitrilotriacetic acid method (14). 
Synthesis of Conjugate Toxins 
Diferric Tf (5  nag) was reacted with N-succinimidyl 3-(2-pyridyldithio) 
proponate (SPDP; Pharmacia Fine Chemicals, Piscataway,  NJ) at a molar 
ratio of5:l (SPDP:Tf) as described (22). Approximately 3-5 SPDP groups 
were added per transferrin molecule, and assayed as previously described 
(28). 
Immediately before coupling, ricin A chain (E. Y.  Laboratories, Inc., 
San Mateo, CA) and DT fragment MspSA (3) were reduced with 1% 13-mer- 
captoethanol for 10 rain at 370C. The reducing agent was removed by G-25 
gel filtration. The reduced protein was collected directly into SPDP-deriva- 
tized Tf(5 mg) on ice, at a ratio of 5 tool of toxin per mol of Tf. After 10 min 
on ice the sample was concentrated, using Macmsolute concentrator B-15 
(Amicon Corp., Danvers, MA), to ,x,6 mg total protein per ml and incubated 
at  room temperature  overnight.  The  mixture  was  then  fractioned on  a 
Sephacryl S-300 column equilibrated with PBS. The fractions were assayed 
for the presence of conjugates by nonreducing PAGE. Fractions containing 
high  molecular mass species (Mr  >  120,000)  were  filter  sterilized and 
stored at 4°C. The protein concentrations in these fractions were estimated 
by measuring the absorbance at 280 nm. 
Toxicity Assay 
To assay the cytotoxicity of the conjugates, 1  x  105 cells were plated per 
well (1  cm  2)  in 24-well plates  16  h  before testing.  The cells were then 
washed three times with medium 2 (med 2:150 mM NaC1, 20 mM Hepes 
pH 7.4,  1 mM CaC12, 5 mM KC1,  1 mM MgC12) and then incubated in 
serum-free Ham's F12 containing the conjugates for 16-18 h. The cells were 
then washed three times with med 2 and incubated with leucine-free MEM 
medium (Gibco) containing 2  IxCi 3H-leu/ml. After a 2-h incubation, the 
incorporation of 3H-leu  into TCA-precipitable material was determined. 
Selection of  Mutants 
A confluent 150-cm  2 flask of WTB cells was mutagenized with 240 ltg/mi 
of ethylmethyl sulfonate (Sigma Chemical Co.) in complete F12 for 16 h at 
37°C. This treatment results in "°50% cell killing. The cells were then pas- 
saged twice in complete F12 over a 6-d period to allow for fixation of the 
mutations.  Half-confluent 100-mm  dishes were then incubated with 5  x 
10  -9 M Tf-RA conjugate in serum-free F12 containing 50 nM monensin for 
18 h. The cells were washed and maintained in complete F12 for 48 h. The 
cells were then treated with 5  x  10  -9 M  Tf-MspSA conjugate in serum- 
free F12 for 18 h. The cells were split 1:2 and maintained for 24 h in com- 
plete FI2. The cells were reselected with 5  x  10  -9 M Tf-MspSA as in the 
second round of selection. 
f-Tf Uptake Assay 
Cells grown on coverslip dishes (30)  were incubated with f-Tf (typically 
20-100 ~tg/ml) in med 2 containing 2 mg/ml ovalbumin for 20 rain at 37°C. 
Fluorescence experiments were conducted using a  Leitz Diavert fluores- 
cence microscope. Video images were obtained using a  DAGE/MTI 65 
MKII SIT camera. 
Transfections 
The human transferrin receptor clone pCDTRI  (17) and pSV3Neo (26)  (10 
~tg pCDTR1  and 2  Ixg pSV3Neo for 5  x  106 cells) were introduced into 
cells by the calcium phosphate coprecipitation technique, with the addition 
of glycerol shock after 5 h (27). After exposure to DNA for 16 h, the cells 
were trypsinized and replated at a 1:3 dilution in complete medium contain- 
ing 400 I.tg/ml G-418 (Gibco). After 10 d the surviving cells were pooled 
and analyzed.  Transfectant cell lines were carried in complete FI2  sup- 
plemented with 400 I.tg/ml G-418. 
Immunofluorescence 
Cells were fixed with 3.7%  formaldehyde (freshly diluted in PBS) for 10 
min. The cells were washed three times with med 2 before incubation with 
5 Ixg/ml human specific anti-Tf-R monoclonal antibody B3/25 (Boehringer 
Mannheim Biochemicals, Indianapolis, IN) in med 2 containing 100 ixg/ml 
saponin and 2  mg/ml ovalbumin for 30 rain at 37°C.  After three 2-min 
rinses with med 2, the cells were incubated with fluorescein-labeled goat 
anti-mouse IgG in the same buffer as the first antibody for 30 rain at 37°C. 
The cells were then washed with med 2 and examined using fluorescence 
microscopy. For comparison with direct uptake of F-Tf the images were 
recorded using the SIT camera. 
Results 
Synthesis of  the Transferrin Conjugate Toxins 
Two conjugate toxins were synthesized in which Tf replaced 
the cell surface-binding domain of the toxin. In one case Tf 
was coupled to ricin A chain and in the other it was coupled 
to a genetically engineered DT fragment MspSA (3). MspSA 
is a cloned DT gene in which the COOH-terminal 17,000  D 
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Synthesis of WTB 
Protein synthesis 
(percentage of 
Treatment  untreated cells) 
Tf-RA (5  x  10  -9 M)  122  +  6 
Tf-RA (5  x  10  -9 M)  +  50 nM monensin  48  5:5 
Tf-RA (5  ×  10  -9 M)  +  50 nM monensin 
+  Tf (2  x  10  '~ M)  105  _+  6 
50 nM monensin  103  +  4 
Unconjugated RA (10  -7 M)  43  +  5 
CHO wild type (WTB) cells were incubated with Tf-RA for 16 h and assayed 
for protein synthesis as described in Materials and Methods. Values are ex- 
pressed as percent of ~H-leu incorporation in untreated control cells. Values 
+SEM, based on three determinations. 
of the B chain,  containing the cell-surface binding site of 
DT, have been deleted. After gel filtration, the conjugate- 
containing fractions were identified by nonreducing PAGE. 
In both cases two distinct bands migrating at the expected lo- 
cation for conjugate species of one and two toxin fragments 
per  Tf molecule were  observed.  The intensities  of these 
bands in Coomassie-stained gels indicated that the two con- 
jugate forms were present in approximately equal amounts. 
The conjugate fractions also contained some unconjugated 
TF (<20%) and free toxin chains (<10%). No attempt was 
made to further purify the conjugates because the uncon- 
jugated toxin fragments are relatively nontoxic when com- 
pared with those conjugated to molecules that provide high 
affinity cell binding (3, 22). 
The two conjugates displayed different activities in an inhi- 
bition of cellular protein synthesis assay.  The TF-RA con- 
jugate, at a concentration of 5  ×  10  -9 M,  had no effect on 
protein synthesis when incubated with WTB cells for 16 h 
(Table I). The toxicity of Tf-RA could be potentiated by incu- 
bation in the presence of 50 nM monensin, which has been 
shown to potentiate the toxicity of ricin and ricin A  chain 
conjugates in other systems (2). When 5  ×  10  -9 M  Tf-RA 
was incubated with cells in the presence of 50 nM monensin, 
protein synthesis was reduced to ,,o50% of the control level 
(Table I). The toxicity was completely blocked by a 500-fold 
excess of Tf. Monensin (50 nM) alone had no effect on pro- 
tein synthesis. 
The Tf-MspSA conjugate was a potent inhibitor of protein 
synthesis, reducing protein synthesis to 50% of  control levels 
at a concentration of 1 ×  10  -~° M  (Fig.  1). A concentration 
of 2  ×  10  -7 M  unconjugated MspSA reduced protein syn- 
thesis to 50% of control level. The effect of the Tf-MspSA 
was completely blocked by inclusion of a 500-fold excess of 
Tf during incubation with the conjugate, demonstrating that 
the specificity of the conjugate is conferred by the Tf  binding 
(Fig.  1). 
The most likely explanation for the differences in the ef- 
fects on protein synthesis is the efficiency with which the A 
chains of the conjugates are able to gain entry to the cyto- 
plasm. The MspSA fragment contains a portion of the DT B 
chain believed to be involved in the transport of the A chain 
into the cytosol (3). Similarly, it has been proposed that por- 
tions of the ricin B chain are also required for efficient cyto- 
solic entry of the A chain (2). In the Tf-RA these regions of 
the toxin are not present, and this could explain lower toxic- 
ity of the Tf-RA conjugate. 
Selection of  Transferrin Receptor-Variant WTB Cells 
The conjugates were used to isolate a Tf-R-variant WTB cell 
line by selection for growth in the presence of the conjugates. 
Three rounds of selection were used to isolate Tf-R-variant 
WTB cells (Materials and Methods). After the third round 
of selection, an aliquot of the surviving cells was tested for 
uptake of f-TF using fluorescence microscopy. A  spectrum 
of f-TF uptake patterns ranging from no detectable uptake 
to apparently normal uptake was observed. Approximately 
40 % of  the cells showed no fluorescein fluorescence, indicat- 
ing that they did not bind or internalize detectable amounts 
of f-Tf. Pure cell lines were isolated by two rounds of single 
cell purification. The f-Tf uptake pattern of 11 cell lines was 
examined and two cell lines, which did not have detectable 
f-Tf uptake, were chosen for further study.  These cell lines 
have been designated TRVa and TRVb. These cell lines have 
been continuously passaged in the absence of selection for 
a period of 6 me without any perceptible alteration, as as- 
sayed by f-Tf uptake, in the receptor-variant phenotype. The 
mutant cells proliferate in complete Ham's FI2 media at a rate 
similar to the parent WTB cells. 
Characterization of Transferrin Receptor-Variant 
CHO Cell Lines 
WTB cells, as do other cell lines (6, 9, 11, 29) juxta-nuclear, 
sequester f-Tf into a para-Golgi compartment comprised of 
small vesicles and tubules (Fig. 2 A; 30). f-Tf  uptake is a sen- 
sitive assay  for cell-associated Tf because the fluorescein 
fluorescence is concentrated into a localized region of the 
cell. To further maximize the sensitivity of the assay, the up- 
take studies were performed using 100 ~tg/mi of f-Tf, which 
is '~20 times the saturating concentration of human  ~25I-Tf 
binding to WTB cells. TRVa cells do not display any cell- 
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Figure 1.  Effect of Tf-MspSA conjugate on WTB cells. WTB cells 
plated in 24 well plates were incubated for 18 h at 37°C in the pres- 
ence of Tf-MspSA (  ); or in the presence of Tf-MspSA and 
a 500-fold excess of Tf (  ....  ). The samples were then assayed for 
protein  synthesis as  described  in  Materials  and  Methods. The 
results are expressed as a percentage of 3H-leu incorporation in 
untreated control cells. 
McGraw et al. Functional Expression of the Human Tf Receptor  209 Figure 2. f-Tf uptake in WTB and TRVa mutant cells. Cells were incubated with 100 ~tg/ml of f-Tf for 20 min at 37°C, rinsed free of ligand, 
and fixed in 3.7% formaldehyde  for 10 min.  (A) Fluorescein fluorescence  of WTB cells.  (B) Phase contrast illumination  of same field 
in a. (C) Fluorescein fluorescence  of TRVa cells, and (D) phase contrast of same field. No f-Tf fluorescence could be detected in the TRVa 
cells;  identical  results  were obtained with TRVb cells. 
associated f-Tf (Fig. 2 C). No para-Golgi fluorescence is ob- 
served indicating that there is no detectable f-'Pf  uptake. Fur- 
thermore, there is no overall increase in cellular fluorescence 
suggesting that TRVa cells are defective in f-Tf binding and 
not in internalization or delivery to the para-Golgi compart- 
ment. Identical results were obtained with the other mutant 
cell line,  TRVb (not shown). 
A more quantitative assessment of Tf binding to the mutant 
cells  was provided by examining the uptake  of ~25I-1T (not 
shown).  No  specific  uptake  was  observed  when  TRVa or 
TRVb cells were incubated at 37°C for 20 min with 7  0g/ml 
125I-Tf (•15  times half-maximal binding concentration). 
The "IT-R-variant phenotype of these cells was correlated 
with their increased resistance to the Tf-MspSA conjugate. 
A  concentration  of  1  x  10  -9  M  Tf-MspSA,  which  com- 
pletely inhibits protein synthesis of the parent cell line, had 
no effect on the mutant cells (Fig. 3). Since Tf-MspSA con- 
centrations above 10-" M reduced protein synthesis of WTB 
cells (Fig.  1), the mutant cell lines are at least 100-fold more 
resistant to the conjugate than the parent cell line.  The in- 
creased resistance is due to a defect in the Tf uptake and not 
due to an inability of DT to intoxify cells  since the mutant 
cells are as sensitive to complete DT as are WTB cells (Fig. 3). 
The  serum protease  inhibitor,  ~tE-macroglobulin,  is  also 
internalized by receptor-mediated endocytosis (30). The pat- 
tern of fluorescein-labeled  a2-macroglobulin uptake in the 
mutant cells was indistinguishable from that of parent WTB 
cells (not shown).  This result,  along with the sensitivity to 
DT, confirms that the mutant cells are specifically defective 
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Figure 3. Effect of Tf-MspSA and DT on WTB, TRVa, and TRVb 
cells.  Cells were incubated with the indicated concentration of DT 
or Tf-MspSA for 18 h and then assayed for protein synthesis as de- 
scribed in Materials  and Methods.  The mutant cell lines are resis- 
tant to "Pf-MspSA but not to DT. 
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munofluorescence of TRVb-1 
cells.  (A) f-Tf uptake  pattern 
of  TRVb-1  cells  incubated 
with 20 I.tg/ml f-Tf for 20 min 
at  37°C.  (B)  Fixed  and  per- 
meabilized  TRVb-I cells were 
treated with a monoclonal an- 
tibody specific for the human 
Tf-R,  followed  by incubation 
with a fluorescein-labeled goat 
antimouse  antibody.  Similar 
results  were  found  with  the 
TRVa-II cells.  In both cases, 
the  fluorescence  was  easily 
observed by conventional  flu- 
orescence  microscopy.  The 
images  shown were recorded 
using a SIT camera. 
in Tf uptake,  presumably due to a  defect in the Tf-R or its 
expression, and are not pleiotropically defective in endocyto- 
sis or in toxin entry. 
Expression of  Human Transferrin Receptor 
in the TRV Cell Lines 
The cDNA clone of the human Tf-R was transfected into the 
mutant cell lines to establish the efficacy of using these cells 
for  studies  of the  function  of the  receptor.  The  cDNA, 
pCDTR1,  was transfected  into both mutant cell lines using 
Ca-phosphate coprecipitation with the dominant selectable 
marker  plasmid  pSV3-Neo.  For transfection  pCDTR1  was 
cut with Barn HI, which releases a 5-kb fragment containing 
the complete cDNA insert plus ,~600 bp of flanking vector 
sequences.  This approach was adopted because when uncut 
pCDTR1  was used  in transfection  experiments,  no expres- 
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Figure 5.  t2sI-Tf  washout studies of WTB, TRVa-U, and TRVb-1 
cells. Confluent monolayer of cells in six well plates were incubat- 
ed with 5 ktg/m112SI-Tf  (540 cpm/ng) for 20 min at 37°C. The cells 
were washed three times with med 2 to remove unbound ligand. The 
cells were reincubated in med 2 containing 100 I~M of the iron che- 
lator  Desferroxamine  (Ciba-Geigy  Corp.,  Greensboro,  NC)  at 
37°C. Under these iron-free incubation conditions the recycled apo- 
Tf does not rebind to cells. At various times after washing, the ~25I 
released  onto the  medium  was determined  by gamma counting. 
Greater than 90% of the released label was TeA precipitable. 
sion of the Tf-R was observed (Ruddle, E, personal commu- 
nication).  The  reason  for the  block in  expression  of the 
receptor gene in the intact pCDTR1 construct is not known. 
The G-418 resistant cells were pooled and screened for up- 
take of f-TE Approximately 30% of the cells were positive 
for f-Tf uptake. The majority of Tf uptake positive cells dis- 
played the expected pattern for Tf internalization: concentra- 
tion of the ligand in the para-Golgi region. Transfection for 
G-418 resistance alone does not alter the Tf-R-variant pheno- 
type of the mutant cells. Pure TF-R-positive transfectant cell 
lines from both TRVa and TRVb were isolated (designated 
TRVa-ll and TRVb-1) and the expression of the human recep- 
tor in these cells was characterized. 
The f-Tf  uptake pattern in the transfectants is indistinguish- 
able from that of WTB cells, with the ligand being rapidly 
concentrated into the para-Golgi compartment (Fig.  4 A). 
Immunofluorescence  of  the  permeabilized  transfectants 
using  a  monoclonal  antibody to  the human  Tf-R,  B3/25, 
confirms that it is the human receptor that is expressed in the 
transfectant cell lines (Fig. 4 B).  The immunofluorescence 
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Figure 6.  Tf-MspSA effect on TRVa-I1 and TRVb-1 cells. The pa- 
rental cell line and the two mutant lines containing transfected hu- 
man Tf-R were assayed for sensitivity to Tf-MspSA. Assay condi- 
tions were identical to those of Fig. 3. The human Tf-R restores 
sensitivity to the toxin conjugate. 
pattern is identical to the f-Tf uptake pattern demonstrating 
that the human Tf-R is sorted into the same region of the cell 
as f-Tf. It is from this compartment, the para-Golgi, that the 
receptor-ligand complex is presumably returned to the cell 
surface. (It should be noted that in CHO cells, because of the 
unavailability  of anti-receptor  antibody,  it  has  not  been 
directly demonstrated that the receptor is recycled to the cell 
surface by the same pathway as Tf.) As expected, the human 
specific monoclonal B3/25  does not stain WTB cells (not 
shown). 
~25I-Tf binding at 4°C to the transfectant cells was exam- 
ined and Kds of 1.6 nM for TRVa-ll and 3.4 nM for TRVb-1 
were estimated from Scatchard plots of the data. This value 
is in accordance with previously reported KdS for human Tf 
binding to human cells (13). TRVa-ll cells were found to have 
25,000  surface receptors/cell, and TRVb-1 to have 150,000 
surface  receptors/cell.  The  disparity  in  expression  of the 
receptor is a feature of the individual transfectants chosen for 
this study and not a characteristic of the mutant cell lines. 
Analysis of other transfectants revealed a similar range of ex- 
pression of the receptor in both TRVa and TRVb transfec- 
tants.  Values  of gd  =  45  nM  and  65,000  surface  recep- 
tors/cell were found for WTB cells. 
Washout studies were performed to establish that f-Tf in- 
ternalized by the human receptor in the transfectants is recy- 
cled. Cells were preloaded with f-Tf  by incubation for 20 min 
at 37°C.  The cells were washed to remove unbound f-Tf and 
reincubated in Tf-free medium containing the iron chelator 
desferoxamine (100 lxM). Desferoxamine was included in the 
media to bind iron and thereby block the iron reloading of 
recycled apotransferrin. The f-Tf fluorescence in the para- 
Golgi of the transfectants was lost over a  40-min period. 
Similar results  were observed in WTB cells.  The loss of 
fluorescence under these conditions is a result of the recy- 
cling of apo-Tf, which in the absence of iron does not bind 
to the receptor at neutral pH. These results indicate that at 
the level of light microscopy the transfected human receptor 
binds Tf, is internalized,  sorted, and recycled in a  fashion 
similar to the CHO receptor. 
The time course of release of 125I-Tf  from the cells was 
studied (Fig. 5). The release of Tf was somewhat slower in 
the transfectants than in WTB cells. In all cases, >90%  of 
the released 125I-Tf  was TCA precipitable, indicating that the 
ligand had not been degraded. 
TRVa and TRVb cells are resistant to the Tf-MspSA con- 
jugate because they are deficient in Tf binding.  Therefore 
transfectant cells should, by virtue of expression of the hu- 
man receptor, have regained sensitivity to the conjugate. As 
shown in Fig. 6 the transfectant cells were sensitive to the ac- 
tion of Tf-MspSA. A direct comparison of the sensitivity of 
the transfectants and the parent cells is not warranted because 
of the  differences in  receptor number and affinity for Tf. 
Regardless, the expression of the human receptor results in 
a reversion of the Tf-MspSA resistant phenotype. 
The ability of the transfectants to accumulate 59Fe from 
Tt~9Fe2  supplied  in  the  medium  was  investigated.  WTB 
cells and both of the transfectants were able to accumulate 
59Fe whereas the mutant cells were not (Fig.  7).  The sgFe 
accumulation in WTB, TRVa-ll, and TRVb-1 cells was in- 
hibited by inclusion of an excess of unlabeled Tf in the incu- 
bation media.  The differences in absolute amounts of 59Fe 
accumulation reflects the differences in the number of Tf-Rs 
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Figure Z Accumulation of 59Fe from Tf59Ee2 WTB ([3), TRVa (,), 
TRVb (o), TRVa-]I  (..), and TRVb-I  (v) were grown in six well 
plates.  The monolayers were washed three times with med 2 and 
incubated at 37°C for the indicated times in reed 2 containing 5 
ttg/ml Tf59Fe2 and 2 mg/ml ovalbumin. Cells were washed free of 
unbound ligand, and solubilized in 0.1 N NaOH and 0.1% Triton 
X-100. Cell-associated  radioactivity  was determined.  The values 
shown have been corrected for nonspecific cell-associated  59Fe by 
inclusion  of  a  500-fold  excess  of unlabeled  differic  Tf.  The 
nonspecific cell-associated 59Fe was constant over the times exam- 
ined and was ,'0300 cpm/mg protein. 
expressed on the different cell lines.  This result documents 
that the human Tf-R can fulfill its biological role in the trans- 
fectants. 
Discussion 
By selection for resistance to two Tf-toxin conjugates, CHO 
cell mutants have been isolated that do not bind detectable 
amounts of Tf. The mutants exhibited at least a  100-fold in- 
creased resistance to the Tf-MspSA conjugate toxin. The mu- 
tant  cells  are  specifically defective in  Tf uptake  and  not 
pleotropically defective in endocytosis as shown by uptake of 
another ligand, ct2-macroglobulin. The increased resistance 
is due to a defect in Tf binding, as the mutants have retained 
sensitivity to DT, indicating that the cells are not blocked at 
the site of toxin action or defective in toxin entry. Because 
the mutant cells were passaged during the three rounds of se- 
lection it is not known whether these cell lines were indepen- 
dently derived or if they have arisen from a common parent. 
The mutation(s) in these cells are stable with no reversion 
in the phenotype observed after continual passage for 6 mo 
in the absence of selection. 
The defect(s) responsible for the Tf-R-variant phenotype 
has not been determined. In our characterization of the mu- 
tants the Tf-R was necessarily detected by assaying for Tf 
binding because antibodies against the CHO receptor are not 
available.  The observed phenotype could result from (a) a 
reduction  in the number of functional cell surface Tf-R to 
<10%  of wild type levels; (b) synthesis of receptors with a 
reduced affinity for "If; (c) no synthesis of the Tf-R. Further 
studies are required to distinguish among these possibilities. 
A  double-selection scheme was used anticipating that a 
significant number of cells would survive due to an alteration 
in the site of toxin action.  Since RA chain (60S ribosomes 
target, reference 21) and DT A chain (elongation factor 2 tar- 
get, reference 21) block protein synthesis at different sites, a 
double-selection scheme would eliminate those cells resis- 
tant due to loss of the target site.  Although it is not known 
whether  such  an  approach  was  necessary,  the  selection 
scheme yielded a high percentage of surviving cells of the 
desired  "If-R-variant phenotype  (40%  had  no  detectable 
binding). The remaining 60 % of the surviving cells have not 
been characterized, and therefore it is not known why they 
survived the selection scheme. 
The  mutant  cells  have been  used  as  recipients  for the 
cDNA clone of the human Tf-R. Stable transfectants express- 
ing the human receptor have been isolated.  The Tf uptake 
pathway, as characterized by ':5I-Tf and f-Tf internalization 
in these cells, is very similar to uptake by the native Tf recep- 
tor in WTB cells. The transfected receptor also functions in 
the delivery of 59Fe to cells as mediated by Tf59Fe2 uptake. 
These  results  demonstrate  that  the  regions  of the  human 
receptor responsible for internalization,  sorting, and recy- 
cling are recognized by CHO cells.  In agreement with this 
result, the human insulin and epidermal growth factor recep- 
tors have been functionally expressed in CHO cells (5,  16). 
Two laboratories have successfully expressed the human 
Tf-R in mouse L cells (17, 19). In both cases the genomic se- 
quences were used for transfection, and the expression of the 
receptor was identified on the surface of the transfected cells 
using  immunofluorescence.  In one case the  receptor  was 
shown to be competent for Tf-mediated Fe uptake by using 
antibodies that specifically block "If binding to the endoge- 
nous mouse Tf-R (19). However in neither study were the en- 
docytic properties of the transfected receptor examined. 
The expression of the human Tf-R in the Tf-R-variant cell 
lines should prove to be a powerful system for the further 
analysis of the structure-function relationship of the Tf-R, 
since in this system the functioning of the transfected recep- 
tor can be followed using the natural ligand. 
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